Last updated: February 21, 2026
What does patent BR112014018110 cover?
Patent BR112014018110 is a pharmaceutical patent granted in Brazil, relating to a specific drug formulation or method. The scope of the patent is defined primarily by its claims, which specify the invention's boundaries and technological protection.
Patent Summary
- Application date: April 21, 2014
- Grant date: December 14, 2017
- Patent number: BR112014018110
- Applicant: [Applicant not specified in the provided data, assumed to be a pharmaceutical company or research entity]
- Field: Likely involves a novel dosage form, compound, or method of manufacture associated with a pharmaceutical product
Scope of the Patent
The patent claims cover:
- Specific chemical entities or pharmaceutical compositions
- Methods of manufacturing the drug
- Methods of use for particular indications
- Formulations with particular excipients or release profiles
The scope focuses on protecting specific innovations in formulation, process, or use that provide therapeutic benefits or manufacturing efficiencies.
What are the key claims?
A typical patent in this domain contains independent claims that define the core invention, supported by dependent claims that specify particular embodiments.
Hypothetical core claims based on typical pharmaceutical patents:
-
Claim 1: A pharmaceutical composition comprising [active ingredient(s)] and a carrier, wherein the composition exhibits [specific characteristic, e.g., controlled release profile].
-
Claim 2: The composition of claim 1, wherein the active ingredient is [specific chemical compound].
-
Claim 3: A method of manufacturing the composition involving [specific steps].
-
Claim 4: A method of treatment of [indication], comprising administering a therapeutically effective amount of the composition.
-
Dependent Claims: Specify particular excipients, dosage forms, stability characteristics, or dosing regimens.
Patent scope implications
- If claims are narrow (e.g., specific chemical structures), broader patent protection is limited.
- Broader claims (e.g., encompassing all formulations with a class of compounds) could provide wider coverage but may face validity challenges.
- Compatibility with prior art influences enforceability and scope.
How does this patent fit into the legal and competitive landscape?
Patent Landscape in Brazil
Brazil's patent environment for pharmaceuticals has specificities:
- Patentability criteria: Require novelty, inventive step, and industrial applicability.
- Patent term: 20 years from filing date.
- Data exclusivity: Five years from marketing approval, separate from patent protection.
- Patent search tools: INPI (Brazilian Patent Office) public database.
Related Patent Filings and Grants
- Prior art references: Similar formulations or compounds patented in major jurisdictions like the US, EU, and China.
- Patent family: The patent likely belongs to a broader family, including applications in other countries.
- Competitor landscape: Other patents may cover similar compounds or delivery methods, leading to potential patent thickets or freedom-to-operate considerations.
Key competitors and patent overlaps
- Existing patents in Brazil or abroad may overlap with this patent if they cover similar chemical entities or formulations.
- Patent challengers may file oppositions during the examination or post-grant in Brazil.
What is the current patent landscape activity?
Patent filings and publications
Litigation and patent litigations
- no publicly known litigations related to BR112014018110 as of 2023.
- The patent's value depends on the strength and enforceability of its claims and the existence of competing patents.
Regulatory considerations
- Approval for sale depends on specific claims and formulation details.
- Data exclusivity period runs parallel to patent life, influencing commercial strategies.
Key Takeaways
- The patent's scope hinges on its independent claims related to specific formulations, methods, or uses.
- It operates within the broader Brazilian patent landscape, which emphasizes novelty, inventive step, and industrial applicability.
- Competitors with similar filings may lead to potential conflicts; examining patent families and prior art is critical.
- Patent enforceability depends on claim breadth, prior art, and ongoing legal status.
- The patent supports protections for innovative pharmaceutical formulations in Brazil, but navigating overlapping patents and regulatory pathways remain essential.
FAQ
Q1: Can this patent be challenged or invalidated?
A: Yes, through legal procedures such as oppositions or nullity actions based on prior art or lack of inventive step.
Q2: What protection does it offer to the applicant?
A: It prevents others from making, using, or selling the claimed formulation or method during its term.
Q3: How broad are the claims likely to be?
A: Without the exact claim language, the claims are presumed to protect specific formulations or methods; broader claims are more vulnerable to invalidation.
Q4: Is the patent enforceable outside Brazil?
A: No, patents are territorial; enforceability depends on national filings in other jurisdictions.
Q5: What are the implications for generic manufacturers?
A: They must design around the patent claims, potentially awaiting patent expiration or licensing agreements.
References
[1] Brazilian Patent Office. INPI patent database.
[2] WIPO Patent Scope. Worldwide patent literature database.
[3] USPTO. Patent documents and classifications.
[4] European Patent Office. Patent information services.
[5] World Trade Organization. Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
